Clinical trial
RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients
NCT00187200 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RESPONSE HF - Response of Cardiac Resynchronization Therapy Optimization With Interventricular (VV) Timing in Heart Failure Patients
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- April 30, 2010
- Enrollment
- 816 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.